The field of soft tissue repair witnessed significant advancements in the United States throughout 2022, with key players making strategic moves and introducing innovative technologies. In this blog post, we’ll explore the noteworthy market developments that took place during the year, focusing on major acquisitions, product launches, and FDA approvals.
August 2022:
CONMED, a prominent player in the medical device industry, made headlines in August by acquiring the medical device start-up, Biorez, Inc. Biorez is dedicated to advancing soft tissue healing through its proprietary BioBrace® Implant technology. The BioBrace® Implant, which has received FDA clearance for multiple product sizes, holds the promise of revolutionizing the soft tissue repair landscape.
July 2022:
Smith & Nephew, a leading orthopedic company, showcased its CAP-FIX◊ Suture Passer at the 2022 American Orthopaedic Society for Sport Medicine (AOSSM) Annual Meeting. This innovative tool is designed to facilitate the passage of sutures through the hip capsule, streamlining the capsular closure procedure. The CAP-FIX◊ Suture Passer is set to make a significant impact on hip-related soft tissue repairs.
May 2022:
Anika Therapeutics achieved a major milestone in May with the FDA clearance of its X-Twist Knotless Fixation system. This platform of suture anchors is specifically designed for mechanical strength, ease of use, and to support healing in key repairs such as rotator cuff repair. The approval of the X-Twist Knotless Fixation system marks a significant step forward in the treatment of rotator cuff injuries.
March 2022:
Stryker, a global leader in medical technology, introduced the Insignia® Hip Stem in March. This engineering marvel is tailored to optimize patient fit and enhance surgeon ease of implantation in muscle-sparing approaches for total hip and hemiarthroplasty procedures. The Insignia® Hip Stem promises improved outcomes in hip-related soft tissue repairs.
February 2022:
In a strategic move, DePuy Synthes, a subsidiary of Johnson & Johnson, expanded its portfolio by acquiring CrossRoads Extremity Systems in February. This acquisition brings a range of procedure-specific, sterile-packed implants and instrumentation systems cleared for lower extremity indications. The addition of CrossRoads Extremity Systems strengthens DePuy Synthes’ position in the soft tissue repair market.
Conclusion: US Soft Tissue Repair Market Developments
The US soft tissue repair market experienced a transformative year in 2022, marked by key acquisitions, groundbreaking product launches, and FDA approvals. These developments not only showcase the industry’s commitment to advancing medical technologies but also highlight the potential for improved patient outcomes in soft tissue repair procedures. As we move forward, it will be exciting to witness how these innovations shape the future of soft tissue repair and contribute to the overall advancement of healthcare.
